1Robert M S,Angus D C,Bryce C L,et al.survival after liver transplanta- tion in the United States a disease specific analysis of the UNOS database [J].Liver Transpl, 2004,10(7 ) : 886-897.
2Moreno B,Berenguer M. Post-liver transplantation medical complica- tions [J].Ann Hepatol, 2006,5(2 ) : 77-85.
7Stegall M D,Everson G,Schroter G,et al. Metabolic complication after liver transplantation[J]. Transplantatioa, 1995(60): 1057-1060.
8Redom J B,Olson L K, Armstrong M B,et al.Effects of trerelimus on human insulin gene expression,insulin mRNA levels and insulin secretion in HIT-T15 cells [J]. J Clin Invest, 1996(98):2768.
9Semhoun S, Ducloux D, Bresson S, et al.Systemic hypertension and re- nal function in long-term liver transplant recipients oncyclosporine [J]. Transplant Proc, 2000( 32):449-452.
10Reuben A. Long term management of the liver transplant patient: diabetes,hyper iipidemia,and obesity[J]. Liver Transplant Surg, 2001 (7): 13-21.
二级参考文献18
1Das A.Cost-effectiveness of different strategies of cytomeg alovirus prophylaxis in orthotopic liver transplant recipients[J].Hepatology,2000,31(2): 311-317.
2Torres A,Ewig S,Insausti J,et al.Etiology and microbial patterns of pulmonary infiltrates in patients wit h orthotopic liver transplantation[J].Chest,2000,117(2): 494-502.
3Singh N,Chang FY,Gayowski T,et al.Fever in liver transpla nt recipients in the intensive care unit[J].Clin Transplant,1999,13(6): 504 -511.
4Lohmann R,Langrehr JM,Klupp J,et al.Infect ious complications after orthotopic liver transplantation with different immunos uppressive induction regimens[J].Transplant Proc,2000,32: 537-538.
5Malkan G,Cattral MS,Humar A,et al.Lamivudine for hepati tis B in liver transplantation: a single-center experience[J].Transplantatio n,2000,69(7): 1403-1407.
6Keeffe EB.End-stage liv er disease and liver transplantation: role of lamivudine therapy in patients wit h chronic hepatitis B[J].J Med Virol,2000,61(3): 403-408.
7Pemetris AJ, Tsamandas AC, Delaney CP, et al. Pathology of liver transplantation. In: Busutill RW, Klintmalm BG, eds.Transplantation of the liver. Philadelphia: WB Saunders, 1996.681-723.
8Menegauz F, Keeffe EB, Andrews BT, et al. Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation, 1994,58: 447-450.
9odd GD, Memel DS, Zaijko AB, et al. Hepatic artery stenosis and thrombosis in transplant recipients: Doppler diagnosis with resistive index and systolic acceleration time. Radiology, 1994,192:657-661.
10Tzakis AG, Gordon RD, Byers W, et al. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation, 1985,40: 667-671.
4Delgado JM, Defeudis FV, Roth RH, et al. Dialytrode for long term intracerebral pedusion in awake monkeys [J]. Arch Int Pbarmacodyn Tber, 1972,198 ( i ) : 9.
5Hara Y, Takuma K, Takano E, et al. Reduced prefrontal dopaminergic activity in valproic aid-treated mouse autism model [ J]. Behav Brain Res, 2015,289 : 39-47. doi : 10.1016/j.bbr.2015. 04.022.
6Hocht C, Di Vemiero C, Opezzo JA. Pharmacokineic- pharmacodynamic ( PK-PD ) modeling of cardio-vascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study [ J ]. Naunyn Schmiedebergs Arch Pharmacol, 2006 , 373 ( 4 ) : 310- 318.
7Nowak G, Ungerstedt J, Wcrnerman J, et al. Metabolic changes in the liver graft monitored continuously with microdialysis during liver transplantation in a pig model [ J ]. Liver Transpl, 2002 , 8 ( 5 ) : 424-432.
8I-Iaugaa H,Thorgersen EB, Pharo A, et al.Early bedside detection of ischemia and rejection in liver transplants by microdialysis [ J]. Liver Transpl, 2012 , 18 ( 7 ) : 839-849. doi : 10.1002/lt. 23425.
